Opiant Pharmaceuticals Inc

NASDAQ:OPNT  
13.50
+0.26 (+1.96%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)59.61M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$8.2 Million
Adjusted EPS-$0.28
See more estimates
10-Day MA$12.96
50-Day MA$12.03
200-Day MA$10.05
See more pivots

Opiant Pharmaceuticals Inc Stock, NASDAQ:OPNT

233 Wilshire Boulevard, Suite 280, Santa Monica, California 90401
United States of America
Phone: +1.310.598.5410
Number of Employees: 30

Description

Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Santa Monica, CA.